CureLogic is a groundbreaking med-tech company harnessing the power of advanced AI to revolutionize personalized medicine. Our proprietary technology rapidly develops targeted microRNA treatments, delivering fast and reliable solutions for critical health conditions.
Focusing on heart disease and cancer—two of the deadliest global health threats—we create personalized therapies designed for maximum accuracy and effectiveness for each individual patient.
At Curelogic, We’re committed to improving healthcare with innovative, customized treatments.
Revolutionizing Healthcare with AI
At CureLogic, we are a cross-disciplinary team of healthcare professionals, AI researchers, clinical data scientists, and technologists united by a single mission, to make precision medicine the new standard of care.
We believe in a future where every patient receives care that’s as unique as their DNA. By leveraging cutting-edge AI, big data, and clinical insight, we help turn complex medical information into actionable strategies, making healthcare more personal, predictive, and powerful. We utilize the power of artificial intelligence, medical imaging, genomics, and clinical data to deliver precision-driven, personalized, and accessible healthcare solutions.
We’re here to bridge the gap between advanced research and real-world care, delivering smarter outcomes, faster decisions, and healthier lives.
Key Benefits:
- A new AI driven method to generate fine tuned miRNA using a state-of-the art AI software
- A new Al powered alignment module to incorporate patient’s transcriptomics, proteomics and metabolomics
- A fully integrated high throughput CRISPR platform for validation.
- Very short turn around time through dedicated soft robotics.
- Fully integrated Al-CRISPR-Imaging platform for ultrafast and validated therapeutics
- Dedicated soft robotics for rapid turnaround times
- Personalised is an upcoming market based on the new big data era
- Current therapeutics are not sufficiently tuned to respond to the new personalised concepts.
- CureLogic offers a one step approach to close this gap.
- Drug treatment dosages are often standardized using weight, surface area, gender but not yet focused on pharmacodynamics, nor disease progression
- Disease progression depends on individual factors including genetic, genomic, proteomic, and environmental factors. These need different dosages and different therapeutics during their progression.
- Precision medicine’s first step is toward making personalised medicine dosages relevant to the specific patient by implementing large data set analysis.
- Personalised medicine aims at using the genetic profile of the individual patient to better treat the disease.
- The Problematic is that the current drug arsenal utilise approximately ~8,000 to 20,000 APIs is not sufficient to treat any disease ~35,000, nor to include diseases’ progress levels which would require at least ~100,000
- We work with bio-inspired microRNA to tackle cellular complexity.
- We modify microRNA (sy-miRNA) to create a repository of ~55M microRNA to tune into signaling pathways using state-of-the art A.I.
- Combinations of sy-miRNA for tuning the severity of disease, increasing the combinations to ~200M new compounds
- Tissue specific microRNA therapeutics to increase dosage and reduce side effects
- Curelogic has developed an integrated platform that combines all our services, affectively creating a one-stop solution for personalized medicine
- The platform consists of the above mentioned A.I. platform coupled to an automatic AI strategy to align patients - omics to the list of proposed synthetic microRNA therapeutics.
- A high throughput CRISPR platform validates the proposed drugs on the patient's own (diseased) cells.
- Rapid turnover is achieved with a dedicated robotic system capable of performing the tasks with a return of 2-3 weeks.
CEO
To make precision medicine accessible, affordable, and effective for every individual.
We exist to eliminate guesswork in healthcare. By merging artificial intelligence with real-time clinical and genetic data, our mission is to empower clinicians with tools that deliver accurate, efficient, and patient-specific insights, when and where it matters most.
We focus on:
1 Delivering personalized care solutions powered by AI
2 Accelerating diagnoses and treatment accuracy
3 Supporting doctors with intelligent clinical decision tools
4 Manufacturing MicroRNA Personalised Signature Drug Treatment for each individual patient
OUR VISION
CureLogic is built on the belief that technology should empower human expertise. That’s why every solution we create is clinically validated, explainable, and designed with patients and practitioners at the center.
Monday – Thursday:
10:00 am – 2:00 pm
Friday:
12:00 am – 3:00 pm
Saturday:
13:00 am – 3:00 pm
Sunday:
10:00 am – 2:00 pm
Our AI genomic research laboratories are at the forefront of integrating advanced artificial intelligence with cutting-edge genomics to accelerate discoveries in human health and disease. We leverage state-of-the-art machine learning and deep learning methodologies to analyze complex genomic datasets, enabling us to identify novel genetic variants, uncover hidden patterns, and improve risk prediction for a range of conditions, including heart diseases, cancer, rare diseases, genetic diseases, and neurodegenerative disorders.
Our multidisciplinary teams develop and deploy automated pipelines for genome and exome sequencing, transforming raw sequencing data into actionable biological and clinical insights. By combining genomic, clinical, and environmental data, our AI-driven approaches facilitate personalized medicine, enhance diagnostic accuracy, and support the development of targeted therapies.
We actively collaborate with leading academic institutions, industry partners, and clinical groups to ensure our research remains at the cutting edge of both genomics, artificial intelligence, and pharmaceutical repository drug discovery. Our commitment to innovation is reflected in ongoing projects that utilise large language models and multimodal AI to automate functional genomics research, streamline data integration, and generate new hypotheses at unprecedented speed.
Through these efforts, our laboratories are not only advancing the science of genomics, diagnostics, and treatment plans, but also transforming the landscape of precision medicine and healthcare.
